1,674 results on '"Caignard, A."'
Search Results
52. Is there tree senescence? The fecundity evidence
53. Linking seed size and number to trait syndromes in trees
54. L’anesthésie topique sans recours à un médecin anesthésiste dans la chirurgie de la cataracte ambulatoire de l’adulte : évaluation des critères de sélection en consultation, à propos de 248 cas
55. Substituted tetrahydroisoquinolines: synthesis, characterization, antitumor activity and other biological properties
56. Comparative Virus-Host Protein Interactions of the Bluetongue Virus NS4 Virulence Factor
57. Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT1/MT2) and serotoninergic (5-HT2C) dual ligands
58. Un'ontologia parassitaria. Immaginario, corpo e politica nell'atmosfera coloniale
59. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
60. Activation of Inflammasome during Bluetongue Virus Infection
61. Supplementary Figure 2 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
62. Supplementary Figure 3 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
63. Supplementary Figure 5 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
64. Data from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
65. Supplementary Figure S2 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
66. Data from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
67. Supplementary Figure 4 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
68. Supplementary Table 1 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
69. Supplemental Table 1 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
70. Supplementary Figure 1 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
71. Supplementary Table 2 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
72. Supplemental Table 3 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
73. Supplemental Table 2 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
74. Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression
75. Urgences en neuro-ophtalmologie
76. New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation
77. Development and Validation of an ELISA for the Detection of Bluetongue Virus Serotype 4-Specific Antibodies
78. Prima emergenza del virus della malattia emorragica epizootica in Europa.
79. Supplemental Table 2 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
80. Data from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
81. Supplementary Figure S2 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
82. Supplementary Figure 5 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
83. Data from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
84. Supplementary Figure 2 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
85. Supplementary Table 2 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
86. Supplementary Figure 1 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
87. Supplementary Figure 4 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
88. Supplemental Table 1 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
89. Supplemental Table 3 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
90. Supplementary Table 1 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
91. Supplementary Figure 3 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
92. Urgences en neuro-ophtalmologie
93. The UVSQ-SAT/INSPIRESat-5 CubeSat Mission: First In-Orbit Measurements of the Earth's Outgoing Radiation.
94. Tick Importin-α Is Implicated in the Interactome and Regulome of the Cofactor Subolesin
95. Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets
96. Increasing spring temperatures favor oak seed production in temperate areas
97. Book Review: Dipesh Chakrabarty. The Climate of History in a Planetary Age
98. Supplementary Data from Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy
99. Supplementary Figure 1 from Regulation of CD4+NKG2D+ Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D Triggering
100. Supplementary Figure 2 from Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor α Chain, Epithelial-to-Mesenchymal Transition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.